Amgen Inc (NASDAQ: AMGN)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 12/23/2022
Closing price: 263.92
| Support price level: | $263.48 |
| Resistance price level: | $278.50 |
| Relative strength index (14-day RSI) | 16.7 |
| Beta | 0.54 |
- Volatility is forecast to fall over the next month.
- AMGN is above its 200-day moving average, providing a measure of support for long positions.
- With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.
| Low | High | Price as % of Range |
| $219.27 | $292.39 | 64.4% |
| 200 day | 50 day | 20 day | 10 day |
| $250.43 | $274.09 | $276.01 | $267.96 |
| Historical (5 year) |
Last month | Current estimate | Next month forecast |
| 24.7% | 21.6% | 20.2% | 23.1% |
- 5.5% in the next week.
- 13.1% in the next month.
- 41.5% in the next year.
